14th Annual Outsourcing in Clinical Trials Conference Set for April 2025

Helpful Information About TBI’s

Additional Case Management information:

Court Closure Announcement for Lima Municipal Court

Support for Pennsylvania Residents Affected by Tropical Storm Debby

Community Action of Orleans & Genesee Opens New Office

Iredell County Court System Goes Digital

Tikun Therapeutics: Pioneering Advances in Familial Dysautonomia

Patient Experience University Opens Its Doors to Healthcare Professionals

Ascertain Secures $10 Million to Revolutionize Healthcare

Virginia Takes Bold Steps to Tackle Medical Debt

News Summary

The 14th Annual Outsourcing in Clinical Trials (OCT) Southeast 2025 conference will take place on April 1–2 in the Research Triangle. This year’s program focuses on the evolving role of patient voices, diversity in trials, and legislative implications, featuring industry experts and discussions on patient-centric considerations.

Exciting Insights Await at the 14th Annual Outsourcing in Clinical Trials Conference

The countdown is on for the 14th Annual Outsourcing in Clinical Trials (OCT) Southeast 2025 conference, set to take place on April 1–2. This year, the event is happening in the heart of the Research Triangle, a hub for innovation and collaboration in clinical research. Attendees can look forward to an engaging exploration of the evolving role of patients in clinical trials and the dynamic relationships between Clinical Research Organizations (CROs) and sponsors.

Raising the Patient Voice

One hot topic at this year’s conference is the increasing significance of the patient voice in shaping clinical research. As the industry continues to evolve, it’s clear that understanding and integrating patient perspectives is not just a nice-to-have; it’s becoming necessary for driving better outcomes. The conference will feature various discussions on how patient involvement can lead to enhanced participation rates, ultimately benefiting clinical research.

Insights from Key Stakeholders

On day one, Richie Khan, the co-founder and COO of a leading patient advocacy consultancy, will dive into the importance of incorporating the patient voice in the clinical development process. His insights will set the stage for a series of discussions led by industry experts like Gabriela Feldberg from AstraZeneca and Bianca Green from UCB. These talks will delve into ways to enhance patient-centric considerations in clinical trials, ensuring that the perspectives and needs of participants are prioritized.

Championing Diversity in Trials

Another crucial aspect of the program will be the emphasis on diversity initiatives in clinical research. Bianca Green will spearhead a discussion focused on diversifying clinical trials, addressing essential factors like race, age, and geography. Given recent political shifts raising concerns about funding cuts aimed at Diversity, Equity, and Inclusion (DEI) initiatives, this conversation is more relevant than ever. Attendees can expect thorough discussions on how to maintain momentum for diversity in the face of adversity.

Community Organizers Making a Difference

A noteworthy afternoon session will spotlight the role of community organizers in reshaping perceptions of clinical research among patient groups. By fostering trust and understanding, these organizers are essential in bridging the gap between clinical trials and the communities they aim to serve. This segment promises to highlight effective strategies that empower patient groups and enhance their connection to ongoing research efforts.

Spark Discussions on Clinical Partnerships

As the conference progresses into day two, the focus will shift toward collaborative experiences in clinical partnerships. Delegates will have the opportunity to engage in candid discussions about their own experiences, facilitating a rich exchange of ideas. This open forum encourages innovative thinking and problem-solving about the best strategies for success.

Exploring Outsourcing Models

A particularly intriguing panel slated for the second day aims to dissect the different outsourcing models that exist between sponsors and CROs. Led by a talented group of experts, this discussion will weigh the pros and cons of Full-Service Outsourcing (FSO) versus Functional Service Provider (FSP) models. It’s a crucial topic for small to medium-sized biotechs navigating the complexities of outsourcing, helping them find the best fit for their unique needs.

Understanding Legislative Challenges

On the legislative front, the conference will highlight the implications of the BIOSECURE Act on the outsourcing landscape. This significant issue will be covered by a speaker from Virpax Pharmaceuticals, delivering critical insights that participants will find invaluable. Given the legislative environment’s direct impact on the industry, understanding these challenges is key for any organization involved in clinical trials.

Mark Your Calendars!

So, mark your calendars and get ready for a thought-provoking event that promises to be filled with engaging discussions, innovative ideas, and networking opportunities galore. As the landscape of clinical trials continues to shift, staying informed and connected is more essential than ever. This year’s OCT conference is sure to leave a lasting impression on all who attend!